AR and neoplasm: Interestingly, the same authors demonstrated GLIexpression in localised prostate cancer; this may be unexpected as primary tumoursare considered to display a predominantly luminal phenotype (i.e.p63−/AR+) but this probably reflects lower GLIactivity compared to more aggressive tumours.